Browsing by Author "Papi, A."

Now showing 1 - 2 of 2

Lower pneumonia risk in COPD patients initiating fixed dose combination (FDC) inhaler comprising extrafine beclometasone dipropionate versus fluticasone
(2022-03) Price, David; Henley, William; Carter, Victoria; Skinner, D; Vella, Rebecca; Papi, A.; Fabbri, Leonardo M; Kertsjens, H; Roche, N; Singh, D; Vogelmeier, C; Sen, E; Cancado, J; Nudo, Elena; Barile, Sara; Georges, George; University of Aberdeen.Institute of Applied Health Sciences; University of Aberdeen.Other Applied Health Sciences
No difference in pneumonia risk in COPD patients initiating fixed dose combination (FDC) inhaler comprising extrafine beclometasone dipropionate versus long-acting bronchodilators
(2022-03-16) Price, David; Henley, William; Carter, Victoria; Skinner, Deborah; Vella, Rebecca; Papi, A.; Fabbri, L M; Kertsjens, H; Roche, Nicolas; Singh, Dave; Vogelmeier, C; Sen, E; Cancado, J; Nudo, Elena; Barile, Sara; Georges, George; University of Aberdeen.Institute of Applied Health Sciences; University of Aberdeen.Other Applied Health Sciences